Management of Chemotherapy Induced Thrombocytopenia
Publication Date: October 9, 2023
Last Updated: November 14, 2023
Use of Platelet Transfusion for Severe CIT
We recommend empiric platelet transfusion for platelet count <10 x109 /L
6731
Thrombocytopenia Receptor Agonists for CIT in Solid Tumors
This subcommittee acknowledges the lack of high-quality data (phase 3 trials) demonstrating efficacy for TPO-RA in the management of CIT. As such, any guidance below regarding the use of TPO-RA in management of CIT should be considered suggestions (or weak recommendations).
Title
Management of Chemotherapy Induced Thrombocytopenia
Authoring Organization
International Society on Thrombosis and Haemostasis